Live Breaking News & Updates on கழுத்து இயலாமை குறியீட்டு

Stay updated with breaking news from கழுத்து இயலாமை குறியீட்டு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Leading Spinal Innovator Dr. Todd Lanman Performs First Two-Level Artificial Cervical Disc Replacement Using the M6-C Disc as Part of FDA Clinical Trial

NuVasive's Simplify Disc Receives FDA Approval for Two-Level Cervical Total Disc Replacement


Share this article
Share this article
SAN DIEGO, April 6, 2021 /PRNewswire/  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the NuVasive Simplify
® Cervical Artificial Disc (Simplify Disc) received approval from the U.S. Food and Drug Administration (FDA) for two-level cervical total disc replacement (cTDR).
This approval is an incredible achievement for the Simplify Disc and further broadens the growth opportunities for the NuVasive C360 portfolio, said Massimo Calafiore, executive vice president, Global Business Units at NuVasive. There is immense surgeon excitement for this latest edition to our cervical offering, and the expanded two-level indication provides greater opportunities to bring the most clinically effective technology in the cTDR market to more patients. ....

United States , North Carolina , Massimo Calafiore , Domagoj Coric , Exchange Commission , Nuvasive Inc , Drug Administration , Atrium Health Carolinas Medical Center , Cervical Artificial Disc , Simplify Disc , Global Business Units , Device Exemption , Neck Disability Index , Disc Heights , International Society , Spine Surgery , Annual Conference , ஒன்றுபட்டது மாநிலங்களில் , வடக்கு கரோலினா , மாசிமோ காலபையோரே , பரிமாற்றம் தரகு , ஏட்ரியம் ஆரோக்கியம் கரோலினாஸ் மருத்துவ மையம் , சிஇஆர்விஐசிஏஎல் செயற்கை வட்டு , எளிமைப்படுத்து வட்டு , உலகளாவிய வணிக அலகுகள் , சாதனம் விலக்கு ,

FDA Approves NuVasive's Simplify Disc For Two-Level Cervical Total Disc Replacement


FDA Approves NuVasive s Simplify Disc For Two-Level Cervical Total Disc Replacement
WASHINGTON (dpa-AFX) - NuVasive, Inc. (NUVA), Tuesday announced that the NuVasive Simplify Cervical Artificial Disc received approval from the U.S. Food and Drug Administration for two-level cervical total disc replacement.
This approval is an incredible achievement for the Simplify Disc and further broadens the growth opportunities for the NuVasive C360 portfolio, said Massimo Calafiore, executive vice president, Global Business Units at NuVasive. There is immense surgeon excitement for this latest edition to our cervical offering, and the expanded two-level indication provides greater opportunities to bring the most clinically effective technology in the cTDR market to more patients. ....

United States , Massimo Calafiore , Nuvasive Inc , Drug Administration , Nuvasive Simplify Cervical Artificial Disc , Simplify Disc , Global Business Units , Device Exemption , Neck Disability Index , ஒன்றுபட்டது மாநிலங்களில் , மாசிமோ காலபையோரே , எளிமைப்படுத்து வட்டு , உலகளாவிய வணிக அலகுகள் , சாதனம் விலக்கு , கழுத்து இயலாமை குறியீட்டு ,